Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Keywords = acute lower respiratory tract infections (ALRI)

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 14182 KiB  
Article
Assessment of Respiratory Health Impacts of PM2.5 by AirQ+ Software in a Sub-Saharan African Urban Setting
by Mélanie Ngutuka Kinzunga, Daniel M. Westervelt, Daniel Matondo Masisa, Freddy Bangelesa, Paulson Kasereka Isevulambire, Thierry Tangou Tabou, Benoit Kabengele Obel, Guillaume Kiyombo Mbela and Jean Marie Kayembe Ntumba
Atmosphere 2024, 15(12), 1518; https://doi.org/10.3390/atmos15121518 - 19 Dec 2024
Cited by 2 | Viewed by 1770
Abstract
Background: Ambient air pollution remains a major risk factor for population health worldwide. The impact of PM2.5 air pollution is underestimated in sub-Saharan Africa due to a lack of epidemiological studies. AirQ+ is proposed to reduce these inequalities in research. The aim [...] Read more.
Background: Ambient air pollution remains a major risk factor for population health worldwide. The impact of PM2.5 air pollution is underestimated in sub-Saharan Africa due to a lack of epidemiological studies. AirQ+ is proposed to reduce these inequalities in research. The aim of this study is to assess, by AirQ+, the impact of prolonged exposure to PM2.5 on respiratory health in Kinshasa in 2019, and to estimate the health benefits of reducing this air pollution. Methods: Population and mortality data were obtained from the Institut National de la Statistique and the Institut de Métrologie et d’Évaluation en santé, respectively. PM2.5 concentrations were measured using PurpleAir PA-II-SD sensors, and average annual concentration was 43.5 µg/m3 in 2019. AirQ+ was used to estimate the health effect attributable to PM2.5 in adults aged over 25 in Kinshasa. Results: In 2019, the proportion of deaths attributable to PM2.5 air pollution was 30.72% for ALRI, 26.55% for COPD and 24.32% for lung cancers. Each 10% reduction in current PM2.5 levels would prevent 1093 deaths (from all causes) per year in Kinshasa. Life expectancy would increase by 4.7 years (CI 3.5–5.3) if the WHO threshold of 5 mg/m3 were respected. Conclusions: The results of this study highlight the major respiratory public health problem associated with air pollution by fine particles in Kinshasa. AirQ+ was used to assess the impact of prolonged exposure to PM2.5 and respiratory deaths among adults in Kinshasa and revealed that this number of deaths could be avoided by improving air quality. Full article
(This article belongs to the Topic The Effect of Air Pollution on Human Health)
Show Figures

Figure 1

17 pages, 905 KiB  
Review
Contribution of Resident Memory CD8+ T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
by Angello Retamal-Díaz, Camila Covián, Gaspar A. Pacheco, Angelo T. Castiglione-Matamala, Susan M. Bueno, Pablo A. González and Alexis M. Kalergis
Pathogens 2019, 8(3), 147; https://doi.org/10.3390/pathogens8030147 - 11 Sep 2019
Cited by 24 | Viewed by 6573
Abstract
Worldwide, human respiratory syncytial virus (RSV) is the most common etiological agent for acute lower respiratory tract infections (ALRI). RSV-ALRI is the major cause of hospital admissions in young children, and it can cause in-hospital deaths in children younger than six months old. [...] Read more.
Worldwide, human respiratory syncytial virus (RSV) is the most common etiological agent for acute lower respiratory tract infections (ALRI). RSV-ALRI is the major cause of hospital admissions in young children, and it can cause in-hospital deaths in children younger than six months old. Therefore, RSV remains one of the pathogens deemed most important for the generation of a vaccine. On the other hand, the effectiveness of a vaccine depends on the development of immunological memory against the pathogenic agent of interest. This memory is achieved by long-lived memory T cells, based on the establishment of an effective immune response to viral infections when subsequent exposures to the pathogen take place. Memory T cells can be classified into three subsets according to their expression of lymphoid homing receptors: central memory cells (TCM), effector memory cells (TEM) and resident memory T cells (TRM). The latter subset consists of cells that are permanently found in non-lymphoid tissues and are capable of recognizing antigens and mounting an effective immune response at those sites. TRM cells activate both innate and adaptive immune responses, thus establishing a robust and rapid response characterized by the production of large amounts of effector molecules. TRM cells can also recognize antigenically unrelated pathogens and trigger an innate-like alarm with the recruitment of other immune cells. It is noteworthy that this rapid and effective immune response induced by TRM cells make these cells an interesting aim in the design of vaccination strategies in order to establish TRM cell populations to prevent respiratory infectious diseases. Here, we discuss the biogenesis of TRM cells, their contribution to the resolution of respiratory viral infections and the induction of TRM cells, which should be considered for the rational design of new vaccines against RSV. Full article
(This article belongs to the Special Issue Virus-Host Interactions of Respiratory Syncytial Virus (RSV))
Show Figures

Figure 1

6 pages, 492 KiB  
Article
A Randomized Controlled Trial of Zinc Supplementation in the Treatment of Acute Respiratory Tract Infection in Thai Children
by Sanguansak Rerksuppaphol and Lakkana Rerksuppaphol
Pediatr. Rep. 2019, 11(2), 7954; https://doi.org/10.4081/pr.2019.7954 - 23 May 2019
Cited by 44 | Viewed by 3812
Abstract
Acute Lower Respiratory Tract Infections (ALRI) are one of the most common causes of morbidity and mortality in young children. Zinc supplementation has been shown to have a preventive effect against respiratory infections, but little evidence is available on its effect on the [...] Read more.
Acute Lower Respiratory Tract Infections (ALRI) are one of the most common causes of morbidity and mortality in young children. Zinc supplementation has been shown to have a preventive effect against respiratory infections, but little evidence is available on its effect on the treatment of ALRI. This study examined the effect of zinc supplementation on the treatment outcome in children that were hospitalized with ALRI. A randomized, doubleblinded, placebo-controlled trial was conducted on 64 hospitalized children with ALRI, who were aged between 2 and 60 months. Children were randomly allocated to receive zinc (30 mg elemental zinc/day) or placebo. The primary outcome was the time to the cessation of ALRI, while the secondary outcomes were the length of the stay in hospital and the individual features of the disease. The study found that ALRI cessation was faster in children who received zinc supplementation (median (IQR): 3 (2-4) days and 4 (3-5) days, respectively; P=0.008), and that their hospital stay was shorter (mean (SD): 3.8 (1.3) days and 6.1 (3.2) days, respectively; P<0.001) than the placebo group. Zinc supplementation was well-tolerated, and no adverse events were reported. In conclusion, zinc supplementation reduced the number of days of ALRI in Thai children, as well as their stay in hospital. Full article
13 pages, 3767 KiB  
Article
Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia
by Francesca Di Giallonardo, Jen Kok, Marian Fernandez, Ian Carter, Jemma L. Geoghegan, Dominic E. Dwyer, Edward C. Holmes and John-Sebastian Eden
Viruses 2018, 10(9), 476; https://doi.org/10.3390/v10090476 - 6 Sep 2018
Cited by 30 | Viewed by 7725
Abstract
There is an ongoing global pandemic of human respiratory syncytial virus (RSV) infection that results in substantial annual morbidity and mortality. In Australia, RSV is a major cause of acute lower respiratory tract infections (ALRI). Nevertheless, little is known about the extent and [...] Read more.
There is an ongoing global pandemic of human respiratory syncytial virus (RSV) infection that results in substantial annual morbidity and mortality. In Australia, RSV is a major cause of acute lower respiratory tract infections (ALRI). Nevertheless, little is known about the extent and origins of the genetic diversity of RSV in Australia, nor the factors that shape this diversity. We have conducted a genome-scale analysis of RSV infections in New South Wales (NSW). RSV genomes were successfully sequenced for 144 specimens collected between 2010–2016. Of these, 64 belonged to the RSVA and 80 to the RSVB subtype. Phylogenetic analysis revealed a wide diversity of RSV lineages within NSW and that both subtypes evolved rapidly in a strongly clock-like manner, with mean rates of approximately 6–8 × 10−4 nucleotide substitutions per site per year. There was only weak evidence for geographic clustering of sequences, indicative of fluid patterns of transmission within the infected population and no evidence of any clustering by patient age such that viruses in the same lineages circulate through the entire host population. Importantly, we show that both subtypes circulated concurrently in NSW with multiple introductions into the Australian population in each year and only limited evidence for multi-year persistence. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Back to TopTop